CXCL13 and in situ carcinoma: Our observation of elevated CSF CXCL13 in CIS patients with presence of OCB and positive MRZR (Figure 2) demonstrates the association of CXCL13 with the polyspecific intrathecal B cell response in MS, which was suggested to derive from long-lived plasma cells in an enhanced B cell-promoting environment [7].